Alida Biosciences Inc.
San Diego, CA Doing business as Alida Biosciences Inc.
- UEI
- G7KLMNRJCFH3
- CAGE
- 8TRS7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 14813 Priscilla St, San Diego, CA 92129, USA
- Website
- alidabio.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pseudouridine detection with single-base resolution in a multiplexed epitranscriptomics assay - abstract chemical… | National Institute of General Medical Sciences | $2,293,570 | |
| Engineered RNA modification recognition - abstract alida biosciences INC is developing a commercial platform for the… | National Institute of General Medical Sciences | $3,247,017 | |
| Engineered RNA modification recognition - abstract alida biosciences INC is developing a commercial platform for the… | National Human Genome Research Institute | $695,306 | |
| Positional marking of RNA modifications - project summary/abstract RNA modifications, which constitute the… | National Human Genome Research Institute | $519,108 | |
| Rapid NGS method for mapping of the epitranscriptome - project summary/abstract epitranscritomics is the study of RNA… | National Human Genome Research Institute | $3,322,335 |
About Alida Biosciences Inc.
Alida Biosciences Inc. is a for-profit biotechnology company located in San Diego, California, focused on developing advanced technologies for epitranscriptomics research. The company specializes in creating innovative analytical platforms and assays designed to detect, identify, and map RNA modifications across entire transcriptomes with high sensitivity and multiplexing capabilities. Registered in SAM.gov since December 2020, Alida Biosciences operates as a corporate entity committed to advancing the understanding of RNA modifications and their potential applications in genomic research, drug development, and clinical diagnostics.
The company has received multiple federal grant awards primarily from the National Human Genome Research Institute and the National Institute of General Medical Sciences, totaling several million dollars. These grants have supported the development of the AlidaBio EpiPlex platform, which aims to provide researchers with a comprehensive method for analyzing RNA modifications such as N6-methyladenosine (m6A), inosine (I), and pseudouridine (Ps). The grant-funded projects have focused on creating commercial technologies for multiplexed RNA modification analysis, including developing engineered RNA modification binding agents, creating sensitive detection methods for clinical samples like needle biopsies and FFPE samples, and establishing a user-friendly workflow with integrated process controls and cloud-based data handling. The research has significant implications for understanding cellular processes, disease progression, and potential therapeutic interventions, particularly in areas like cancer research, drug resistance, and viral infection.
Quick answers
What is Alida Biosciences Inc.'s UEI?
Alida Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is G7KLMNRJCFH3.
What is Alida Biosciences Inc.'s CAGE code?
Alida Biosciences Inc.'s CAGE code is 8TRS7.
What is Alida Biosciences Inc.'s primary NAICS code?
Alida Biosciences Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Alida Biosciences Inc. located?
Alida Biosciences Inc.'s physical address in SAM.gov is 14813 Priscilla St, San Diego, CA 92129, USA.
Is Alida Biosciences Inc. registered in SAM.gov?
Yes. Alida Biosciences Inc.'s SAM.gov registration is active through June 5, 2027.
What is Alida Biosciences Inc.'s most recent federal award?
Alida Biosciences Inc.'s most recent federal grant award is Pseudouridine detection with single-base resolution in a multiplexed epitranscriptomics assay - abstract chemical… (R44GM159469), from National Institute of General Medical Sciences, on August 15, 2025.
On GovTribe
See Alida Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors